Quality of Women's Health Care
Indicators of the quality of health care can provide important information about the effectiveness, safety, and timeliness of women’s health services. While there are numerous ways to measure quality of care, some common indicators used to monitor women’s health care in managed care plans include screening for chlamydia, screening for cervical cancer, and the receipt of timely prenatal and postpartum care.
In 2008, women aged 21–24 years enrolled in Medicaid were more likely than those enrolled in commercial plans to have had a chlamydia screening (59.4 versus 43.5 percent, respectively). Since 2000, the percentage of sexually active females screened for chlamydia has increased by 110 percent among those in commercial plans and 56.7 percent among Medicaid participants.
Cervical cancer screenings appeared to be more accessible to women with commercial coverage than to those covered by Medicaid. Among women aged 18–64 years, cervical cancer screenings were received at least once during the previous 3 years by 80.8 percent of commercially-insured women and 66.0 percent of those covered by Medicaid (data not shown).
In 2008, women with commercial insurance coverage were more likely than those with Medicaid to have received timely prenatal and postpartum care. More than 92 percent of commercially-insured women received prenatal care in either their first trimester or within 42 days of enrollment, compared to 81.9 percent of those covered by Medicaid. Similarly, 82.8 percent of women with commercial coverage had a postpartum visit between 21 and 56 days after delivery, compared to 62.7 percent of women participating in Medicaid. Since 2003, the percentage of postpartum women receiving timely care increased 13.4 percent among Medicaid participants and 3.1 percent among commercially-insured women.